https://orcid.org/0000-0001-5277-4962
Citations (23)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Alexis Q. Dean, Shen Luo, Julianne D. Twomey & Baolin Zhang. (2021) Targeting cancer with antibody-drug conjugates: Promises and challenges. mAbs 13:1.
Read now
Read now
Articles from other publishers (22)
Karoline Bechtold-Peters, Andrea Ruggiero, Nienke Vriezen, Nathan Ihle, Armin Klein, Charles Morgan, Daniel Schweizer, Dengfeng Liu, Fred Jacobson, Jakob Buecheler, Mark Panek, Naomi Duggan, Padma Malyala, Philippe Dupraz, Priyanka Desai, Shufang Niu, Yiqing Feng & Xiangyang Wang. (2023) CMC Regulatory Considerations for Antibody-Drug Conjugates. Journal of Pharmaceutical Sciences 112:12, pages 2965-2980.
Crossref
Crossref
Mingyan Cao, G. Patrick Hussmann, Yeqing Tao, Ellen O’Connor, Conner Parthemore, Diana Zhang-Hulsey, Dengfeng Liu, Yang Jiao, Niluka de Mel, Meagan Prophet, Samuel Korman, Jaytee Sonawane, Christina Grigoriadou, Yue Huang, Scott Umlauf & Xiaoyu Chen. (2023) Atypical Asparagine Deamidation of NW Motif Significantly Attenuates the Biological Activities of an Antibody Drug Conjugate. Antibodies 12:4, pages 68.
Crossref
Crossref
Renato Kaylan Alves França, Igor Cabral Studart, Marcus Rafael Lobo Bezerra, Larissa Queiroz Pontes, Antonio Marcos Aires Barbosa, Marcelo Macedo Brigido, Gilvan Pessoa Furtado & Andréa Queiroz Maranhão. (2023) Progress on Phage Display Technology: Tailoring Antibodies for Cancer Immunotherapy. Viruses 15:9, pages 1903.
Crossref
Crossref
Devesh Aggarwal, Jie Yang, Md. Abdus Salam, Sagnik Sengupta, Md. Yusuf Al-Amin, Saad Mustafa, Mohammad Aasif Khan, Xun Huang & Jogendra Singh Pawar. (2023) Antibody-drug conjugates: the paradigm shifts in the targeted cancer therapy. Frontiers in Immunology 14.
Crossref
Crossref
Alistair R. Hines, Matthew Edgeworth, Paul W. A. Devine, Samuel Shepherd, Nicholas Chatterton, Claire Turner, Kathryn S. Lilley, Xiaoyu Chen & Nicholas J. Bond. (2023) Multi-Attribute Monitoring Method for Process Development of Engineered Antibody for Site-Specific Conjugation. Journal of the American Society for Mass Spectrometry 34:7, pages 1330-1341.
Crossref
Crossref
Robin Schiemer, Jan Tobias Weggen, Katrin Marianne Schmitt & Jürgen Hubbuch. (2023) An adaptive soft‐sensor for advanced real‐time monitoring of an antibody‐drug conjugation reaction. Biotechnology and Bioengineering 120:7, pages 1914-1928.
Crossref
Crossref
Jan Tobias Weggen, Janik Seidel, Ryan Bean, Michaela Wendeler & Jürgen Hubbuch. (2023) Kinetic studies and CFD-based reaction modeling for insights into the scalability of ADC conjugation reactions. Frontiers in Bioengineering and Biotechnology 11.
Crossref
Crossref
Douglas Dias e Silva, Guilherme Malandrini Andriatte & Roberto Carmagnani Pestana. (2022) Antibody-Drug Conjugates and Tissue-Agnostic Drug Development. The Cancer Journal 28:6, pages 462-468.
Crossref
Crossref
Thavasyappan Thambi, JinWoo Hong, A-Rum Yoon & Chae-Ok Yun. (2022) Challenges and progress toward tumor-targeted therapy by systemic delivery of polymer-complexed oncolytic adenoviruses. Cancer Gene Therapy 29:10, pages 1321-1331.
Crossref
Crossref
Bin-Bin Shen, Jun-Jie Yuan, Ci Qian, Han Gao & Wei-Jie Fang. (2022) Investigation of an artifact during non-reduced capillary electrophoresis with sodium dodecyl sulfate analysis utilizing N-ethylmaleimide as an alkylation reagent. Analytical Biochemistry 655, pages 114833.
Crossref
Crossref
Fei Wu, Thomas C. Gardinier, Melik Z. Turker, Feng Chen, Pei-Ming Chen, Aranapakam M. Venkatesan, Vaibhav Patel, Gregory P. Adams, Michelle S. Bradbury, Ulrich B. Wiesner, Geno Germano & Kai Ma. (2022) Molecular Engineering of Surface Functional Groups Enabling Clinical Translation of Nanoparticle–Drug Conjugates. Chemistry of Materials 34:12, pages 5344-5355.
Crossref
Crossref
Simon K. Krebs, Nathanaël Rakotoarinoro, Marlitt Stech, Anne Zemella & Stefan Kubick. (2022) A CHO-Based Cell-Free Dual Fluorescence Reporter System for the Straightforward Assessment of Amber Suppression and scFv Functionality. Frontiers in Bioengineering and Biotechnology 10.
Crossref
Crossref
Marco Cavaco, Miguel A. R. B. Castanho & Vera Neves. (2022) The Use of Antibody-Antibiotic Conjugates to Fight Bacterial Infections. Frontiers in Microbiology 13.
Crossref
Crossref
M. Murali, A. R. Kumar, B. Nair, K. Pavithran, A. R. Devan, G. K. Pradeep & L. R. Nath. (2021) Antibody–drug conjugate as targeted therapeutics against hepatocellular carcinoma: preclinical studies and clinical relevance. Clinical and Translational Oncology 24:3, pages 407-431.
Crossref
Crossref
Mingyan Cao, Niluka De Mel, Jihong Wang, Conner Parthemore, Yang Jiao, Weimin Chen, Shihua Lin, Dengfeng Liu, Greg Kilby & Xiaoyu Chen. (2022) Characterization of N-Terminal Glutamate Cyclization in Monoclonal Antibody and Bispecific Antibody Using Charge Heterogeneity Assays and Hydrophobic Interaction Chromatography. Journal of Pharmaceutical Sciences 111:2, pages 335-344.
Crossref
Crossref
Yuanli Song, Hui Cai, Zhijun Tan, Nesredin Mussa & Zheng-Jian Li. (2022) Mechanistic insights into inter-chain disulfide bond reduction of IgG1 and IgG4 antibodies. Applied Microbiology and Biotechnology 106:3, pages 1057-1066.
Crossref
Crossref
Carolina T. Orozco, Matthew J. Edgeworth, Paul W. A. Devine, Alistair R. Hines, Owen Cornwell, Christopher Thompson, Xiangyang Wang, Jonathan J. Phillips, Peter Ravn, Sophie E. Jackson & Nicholas J. Bond. (2021) Interconversion of Unexpected Thiol States Affects the Stability, Structure, and Dynamics of Antibody Engineered for Site-Specific Conjugation. Bioconjugate Chemistry 32:8, pages 1834-1844.
Crossref
Crossref
TaeJin Lee, Ju Hwan Kim, Se Jeong Kwon, Sun Hee Park, Jinyoung Kim, Hyo Jin Kang & Sang J. Chung. (2020) Photoconjugation of an Fc-Specific Peptide Enables Efficient DAR 2 Antibody–Drug Conjugate Formation. Organic Letters 22:21, pages 8419-8423.
Crossref
Crossref
Toby Passioura. (2019) The Road Ahead for the Development of Macrocyclic Peptide Ligands. Biochemistry 59:2, pages 139-145.
Crossref
Crossref
Srikanth Kotapati, David Passmore, Sayumi Yamazoe, Rajesh Kishore Kumar Sanku, Qiang Cong, Yam B. Poudel, Naidu S. Chowdari, Sanjeev Gangwar, Chetana Rao, Vangipuram S. Rangan, Pina M. Cardarelli, Shrikant Deshpande, Pavel Strop, Gavin Dollinger & Arvind Rajpal. (2019) Universal Affinity Capture Liquid Chromatography-Mass Spectrometry Assay for Evaluation of Biotransformation of Site-Specific Antibody Drug Conjugates in Preclinical Studies. Analytical Chemistry 92:2, pages 2065-2073.
Crossref
Crossref
Chen Bai, Emily E. Reid, Alan Wilhelm, Manami Shizuka, Erin K. Maloney, Rassol Laleau, Lauren Harvey, Katie E. Archer, Dilrukshi Vitharana, Sharlene Adams, Yelena Kovtun, Michael L. Miller, Ravi Chari, Thomas A. Keating & Nicholas C. Yoder. (2019) Site-Specific Conjugation of the Indolinobenzodiazepine DGN549 to Antibodies Affords Antibody–Drug Conjugates with an Improved Therapeutic Index as Compared with Lysine Conjugation. Bioconjugate Chemistry 31:1, pages 93-103.
Crossref
Crossref
Donmienne Leung, Jacqueline Wurst, Tao Liu, Ruben Martinez, Amita Datta-Mannan & Yiqing Feng. (2020) Antibody Conjugates-Recent Advances and Future Innovations. Antibodies 9:1, pages 2.
Crossref
Crossref